Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Expert Rev Respir Med ; 15(12): 1589-1595, 2021 12.
Article in English | MEDLINE | ID: mdl-34018900

ABSTRACT

Background: Sarcoidosis is multisystem inflammatory granulomatosis that can potentially affect any organ of the human body. We aimed to estimate the prevalence of diabetes mellitus (DM) in sarcoidosis patients and determine the association between sarcoidosis and DM.Method: All relevant articles reporting the prevalence of DM in sarcoidosis published until September 19th, 2020, were retrieved from ten electronic databases. We used the random effect model to perform the meta-analysis.Results: After screening 2,122 records, we included 19 studies (n = 18,686,162). The prevalence of DM in sarcoidosis patients was 12.7% (95% CI 10-16.1). The prevalence was highest in North America with 21.3% (13.5-31.8), followed by Europe 10.4 (7.9-13.7) and Asia 10% (1.8-39.7). Sarcoidosis patients had higher rates of DM compared to controls (OR 1.75; 95% CI 1.49-2.05). Sensitivity analysis, after removing the largest weighted study, did not reveal any effect on the significance of the results (OR 1.73; 95% CI 1.33-2.25).Conclusion: The prevalence of DM in sarcoidosis is considerably high, with increased odds of DM in sarcoidosis compared to healthy controls. Further research with a wide range of confounders is required to confirm the association of sarcoidosis with DM.


Subject(s)
Diabetes Mellitus , Sarcoidosis , Databases, Factual , Diabetes Mellitus/diagnosis , Diabetes Mellitus/epidemiology , Europe , Humans , Prevalence , Sarcoidosis/diagnosis , Sarcoidosis/epidemiology
2.
Vet Parasitol Reg Stud Reports ; 20: 100396, 2020 04.
Article in English | MEDLINE | ID: mdl-32448521

ABSTRACT

Cysticercus tenuicollis, the larval stage of Taenia hydatigenia, infects sheep and causes economic losses due to condemnation of infected organs. This study was designed to report the infection rate, risk factors, biochemical, and molecular characterization of Cysticercus tenuicollis in sheep from Ashmoun, Minoufiya, Egypt. The infection rate was 18%. The age was a risk factor for infection where there was a significant difference in infection rate between sheep more than 3 years and sheep under 3 years of age. There was no significant difference between infection in male and female groups. The liver had the highest organ distribution followed by omentum. Biochemical analysis of the cyst fluid showed some variations in the levels of ALT, AST, triglycerides, cholesterol, total protein, urea nitrogen, calcium, sodium, chromium, potassium than the levels identified in Algeria, Iraq, and Iran. PCR and sequence analysis of cox1 and ssrRNA showed that the sequences from Minoufiya, Egypt were highly identical to the related ones from several countries and confirmed the cyst is Cysticercus tenuicollis. This study reported the infection rate, risk factors, biochemical analysis, and molecular characterization of Cysticercus tenuicollis in sheep from Minoufiya, Egypt.


Subject(s)
Cysticercosis/veterinary , Cysticercus/isolation & purification , Sheep Diseases/epidemiology , Age Factors , Animals , Cysticercosis/epidemiology , Cysticercosis/parasitology , Cysticercus/classification , Cysticercus/genetics , Egypt/epidemiology , Prevalence , Risk Factors , Sheep , Sheep Diseases/parasitology , Sheep, Domestic
4.
Lipids Health Dis ; 11: 85, 2012 Jul 02.
Article in English | MEDLINE | ID: mdl-22747902

ABSTRACT

Oxidized low density lipoprotein (ox-LDL), a risk factor of atherosclerosis, facilitates the formation and vulnerability of atherosclerotic plaque, thus contributing to several clinical complications. Stem cells participate in vascular repair after damage and atherosclerosis is a process of inflammation accompanied with vascular injury. Researchers have proposed that stem cells participate in the formation of atherosclerotic plaque. Also, because ox-LDL is capable of inducing toxic effects on stem cells, it is reasonable to postulate that ox-LDL promotes the progress of atherosclerosis via acting on stem cells. In the present article, we review the relationship between ox-LDL, stem cells, and atherosclerosis and a portion of the associated mechanisms.


Subject(s)
Atherosclerosis/metabolism , Coronary Artery Disease/metabolism , Lipoproteins, LDL/physiology , Stem Cells/metabolism , Animals , Atherosclerosis/pathology , Atherosclerosis/prevention & control , Coronary Artery Disease/pathology , Coronary Artery Disease/prevention & control , Humans , Hydroxymethylglutaryl-CoA Reductase Inhibitors/pharmacology , Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use , Lipoproteins, LDL/metabolism , Oxidative Stress , Signal Transduction , Stem Cells/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...